C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 5/00 (2006.01) C12Q 1/00 (2006.01) G01N 33/50 (2006.01) C07K 14/47 (2006.01) C07K 14/82 (2006.01) C12N 5/06 (2006.01) C12N 5/08 (2006.01)
Patent
CA 2610324
We plan to combine (among others) use transcription factors Oct-4, Nanog and Sox2 to suppress genes to keep our stem cell inventory (proliferation strategy) and from differentiation and cell surface antigens including glycolipids SSEA3 and SSEA4 and the keratan sulfate antigens Tra-1-60 and Tra-1-81, all of the above to keep the stem cells in their stem cells forms (from differentiation) of pluripotency. We can also add telomerase. We add to this process, oncogene c-Myc, especially if the cell colonies start to differentiate, the purpose is to reverse differentiate the cells into pluripotency state. We then set up the medium we are considering several alternatives or combination (even all together). 1) Ectogenesis (eg. artificial uterus and fallopian tube cell) as medium for stems also. 2) Slowly and gently pumping in perflubron (oxygen supply) and nutrients, glucose (we could synthesize amino acids), such as those found in amniotic fluid. We need to come up with the best recipe of alanine, arginine, aspartic acid, isoleucine, cysteine, glutamic acid + glutamine, glycine, leucine, lysine, methionine, phenylalanine, proline, taurine, threonine, serine, valine (and possibly tyrosine) in and out in ebb and flow, including to flow to wash out waste. Additionally we need to add NaHCO3 and possibly antibiotics (we could possibly emulsify egg yolk such as from a chicken; and also inorganic salts such as Na+, K+, Ca2+, Cu2+, Zn2+ and CO2+) as well as vitamins. 3) Other medium are made from (heat-inactivated possibly fetal; liver; spleen) Bovine (serum albumin), Lamb, pig, 2-mercaptoethanol... 4) Prepared Mediums include Dulbecco's (GIBCO; Eagle's), Krebs-Ringer bicarbonate medium as well as glucose, lactate, and pyruvate, Chocolate Agar, JRH-SFM 5) We also add Wnt (possibly micro inject into the nuclear membrane), Leukemia Inhibitory Factor (LIF), STAT 3, Fiberoblast Growth Factor (bFGF or FGF-2), Human Choronic Gonadotropin agonist leuprolide (GnRH) (peptide hormones), paracine - acting factor, Stem Cell Factor (SCF) building blocks (to establish receptors) for c-kit and mRNA increased successful functionality and also cytokine G-CSF and GM-CSF. We could also add Heparin-binding growth factors (eg. HBGF-1 and HGBF-2). 6) Other medium includes JRH Biosciences' Excel 620 serum-free medium (JRH- SFM). (Passaging of cells are used to further proliferate stem cells) Accutase (Innovative Cell Technologies Inc., distributed by PAA) and triturated approximately 10 times using a pipette. Then, the cell suspension was incubated. Dissociated cells were centrifuged at 120 rcf and resuspended. An aliquot was counted by trypan blue exclusion assay in a hemocytometer to determine the amount of viable cells. Cells (10 5) were plated in T75 culture flasks for long-term passaging (culture medium (coated with fibronectin/lanmine) per flask). All media contained 1-glutamine, penicillin/streptomycin, heparin (Sigma), bFGF (R&D Systems), and EGF (R&D Systems). A total of 10 4 cells per well were seeded in 12-well plates in a volume of 1 ml and grown under standard conditions. After a few days the grown stem cells were counted and dissociated by Accutase, and viable cells were counted by trypan blue exclusion assay in a hemocytometer. In addition to substituting to male somatic DNA for female Oocyte nucleus we can see below... Stem Cells from female eggs can be obtained as follows: 1) Treat the eggs with oncogene c-Myc. 2) Hyper ovulate (use of fertility drugs) 3) Harvest eggs. 4) Mature them in CMRL-1066 media (Sigma), FCS (HyClone), pregnant mare serum (Sigma), human chrionic gonadotropin (Sigma), penicillin, streptomycin. 5) The eggs are incubated in CO2, inonomycin, then in 6-dimethyllaminopurine. 6) The stem cells are then removed and further media are similar to the media above (stem cell tissue culture - especially proliferation; since before we can treat patients we need sizable inventory of compatible stem cells first). 7) We could use electroshock, heat shock to get the stem cells to start dividing. 8) We could also use the above maturation cycle and incubation to proliferate stem cells produced by the traditional method (eg. Oocyte removed nucleus, micro; laser; electro shock and replaced with somatic DNA). 9) Alternatively we could use primordial germ cells from an adult male and use the above maturation cycle and incubation to proliferate stem cells. 10) Another alternative is to use a batch of stem cells (from any of the above methods) that have stopped proliferating and either treat with the maturation cycle, then incubate to jump start the proliferation cycle again. 11) Or we could use a batch of stem cells (from any of the above methods) and microinject, laser electroshock the DNA from the stem cells (that have stopped proliferating) into a fresh Oocyte (with the nucleus removed). 12) We could also alternate between 10) and 11) or test which one is the most prolific and which one is best for maintaining the integrity of the DNA - from mutating or degenerating. We are looking at developing an fMRI or MRI (with adjustable pixelation to match the sharpness/detail as the magnification increases) - electron microscope (that can track the motion of tracker) and perhaps more important, as well the fMRI or MRI and/or PET also a tiny probe, lens similar to the video (real time) probes used by surgeons to pass through blood stream, except our video probe will be (eg, possibly with fiberoptic or diamond lens - due to the small size of the lens we need a lens that won't become brittle at that size) at the cellular level. It will enter the cell membrane via a prick of a needle and be able to probe around the inside the cell (we could also surround the probe with gel so the cell does not leak). The purpose for a video probe is to observe the interior of the cell in colour and carry out dye and stain phospherousent (fluorescence). We might include infrared capabilities in our probes. We use the dye and stain on inputs such as Oncogene c-Myc, different chemicals, different enzymes, different, growth factors, different amino acids, and also glucose and oxygen and carbon dioxide and differing levels wastes all in differing amounts (also salts) as well as all mediums, including maturing mediums, incubation mediums, passaging mediums, and ectogenesis mediums. We observe which of these passes through the cell membrane: 1) By osmosis (hydrophobicity and lipophilicity process) what level of concentration of organic salts are optimal for cell health and their ability to carry other of the inputs above as they pass through the cell membrane. 2) Protein receptors which protein receptors bind to which inputs and how (mechanism) these receptors operate to bring the inputs in and deliver to the right user. 3) Why the protein receptors (bis-peptides) selects a particular input. 4) We can watch the cell organelles (internal structures - also DNA intake and outtake of chemicals entering and exiting the nuclear membrane and the ability of the nucleotides to sense feedback an how it releases which chemicals and which parts of the organelles react eg. mRNA to carry out instructions which nucleotides activate and deactivate consistently before a cell division and which deactivate when the cells stop proliferating) in terms of changing size, shape (observing possibly for real time pulsating or other indicators of activity) and location over various time horizons (what in the early eg. moment by moment, what in cytoplasm facilitates optimal proliferation versus late stage proliferation, why does the proliferation slow down even with growth factors, what and why is the cell make up eg. the organelles responding - reacting to to slowing down late stage proliferation) in real time (or video recorded) as an indication of activity of a particular organelle or of vertical chain requiring more than one type of organelle to put the input into a usable form - 1. are the output from the organelles' use of the input in a new form? 2. where is this output to be used? 3. How does it get there? 4. And what is its contribution to the process
Na
Voon Gerald
LandOfFree
Stem cells methods, technologies, vertical processes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stem cells methods, technologies, vertical processes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stem cells methods, technologies, vertical processes will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1530981